cholestyramine resin has been researched along with Hyperlipoproteinemias in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (86.21) | 18.7374 |
1990's | 4 (13.79) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoidal, JR; Hunninghake, DB; Ludwig, PW | 1 |
Augustin, J | 1 |
Barthel, U; Haller, H; Hanefeld, M; Hora, C; Rothe, G; Schulze, J | 1 |
Widhalm, K | 2 |
Tan, MH | 1 |
Azarnoff, DL; Saunders, RN | 1 |
von Bock und Polach, U | 1 |
Rogers, MP | 1 |
Fears, R; Rush, WR | 1 |
Arteaga, A; Lathrop, R; Maiz, A | 1 |
Jenkins, AL; Jenkins, DJ; Jepson, EM; Leeds, AR; Reynolds, D; Slavin, B | 1 |
Schwandt, P; Weisweiler, P | 1 |
Hanefeld, M | 1 |
Barnhart, HX; Sampson, AR | 1 |
Matsuzawa, Y; Nakamura, T | 1 |
Kesten, S; Maurer, J; Mayne, L; Scavuzzo, M | 1 |
Lawrie, TD; Morgan, HG; Packard, CJ; Shepherd, J; Stewart, JM; Third, JL | 1 |
Leijd, B | 1 |
Gianfranceschi, G; Pazzucconi, F; Sirtori, CR; Sirtori, M | 1 |
Rywik, S | 1 |
Davignon, J | 1 |
Blum, CB; Levy, RI | 1 |
Mikunis, RI; Serkova, VK | 1 |
Stuyt, PM | 1 |
Levy, RI; Schaefer, EJ | 1 |
Gotto, AM | 1 |
Parker, F | 1 |
4 review(s) available for cholestyramine resin and Hyperlipoproteinemias
Article | Year |
---|---|
HDL-cholesterol: the negative risk factor for coronary heart disease.
Topics: Adult; Age Factors; Alcoholism; Child; Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Dietary Fats; Female; Humans; Hyperlipoproteinemias; Infant, Newborn; Lipoproteins, HDL; Male; Nicotinic Acids; Obesity; Physical Exertion; Racial Groups; Risk; Sex Factors; Smoking | 1980 |
Current status of drugs used to treat hyperlipoproteinemias.
Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols | 1982 |
[Drug treatment of hyperlipoproteinemia: bile acid-binding resins].
Topics: Anticholesteremic Agents; Arteriosclerosis; Bile Acids and Salts; Cholestyramine Resin; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemias; Liver; Receptors, LDL | 1994 |
Pathogenesis and management of lipoprotein disorders.
Topics: Abetalipoproteinemia; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestyramine Resin; Chylomicrons; Colestipol; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Hypobetalipoproteinemias; Hypolipoproteinemias; Infant; Infant, Newborn; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Tangier Disease | 1985 |
5 trial(s) available for cholestyramine resin and Hyperlipoproteinemias
Article | Year |
---|---|
[Primary prevention of coronary disease by modification of the lipids].
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dietary Fats; Double-Blind Method; Humans; Hyperlipoproteinemias; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Placebos; Risk | 1984 |
Current status of drugs used to treat hyperlipoproteinemias.
Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols | 1982 |
The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program.
Topics: Adult; Canada; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Humans; Hyperlipoproteinemias; Male; Middle Aged; United States | 1979 |
Efficacy of cholestyramine does not vary when taken before or during meals.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Administration Schedule; Eating; Female; Humans; Hyperlipoproteinemias; Male; Middle Aged; Triglycerides | 1991 |
[Is hypolipemic treatment effective as a preventive measure?].
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Europe; Humans; Hypercholesterolemia; Hyperlipoproteinemias; International Cooperation; Male; Middle Aged | 1989 |
21 other study(ies) available for cholestyramine resin and Hyperlipoproteinemias
Article | Year |
---|---|
Increased leucocyte oxidative metabolism in hyperlipoproteinaemia.
Topics: Arteriosclerosis; Cholestyramine Resin; Free Radicals; Humans; Hyperlipoproteinemias; Lipoproteins; NADP; Neutrophils; Oxidation-Reduction; Oxygen; Risk; Superoxides | 1982 |
Reduced incidence of cardiovascular complications and mortality in hyperlipoproteinemia (HLP) with effective lipid correction. The Dresden HLP study.
Topics: Adolescent; Adult; Cerebrovascular Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Combined Modality Therapy; Dietary Fats; Drug Therapy, Combination; Germany, East; Humans; Hyperlipoproteinemias; Middle Aged; Myocardial Infarction; Niacin; Physical Exertion; Triglycerides | 1984 |
Serum lipoproteins during childhood: normal concentrations and primary hyperlipoproteinemias.
Topics: Child; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Diet; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL | 1982 |
[Lowering lipids rapidly and permanently with etofibrate].
Topics: Cholestyramine Resin; Clofibrate; Clofibric Acid; Dextrothyroxine; Humans; Hyperlipoproteinemias; Lipoproteins, HDL; Liver; Nicotinic Acids; Sitosterols | 1982 |
Plasma lipoprotein metabolism in relation to ischaemic heart disease.
Topics: Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Hyperlipoproteinemias; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides | 1982 |
The role of cholesterol 7 alpha-hydroxylase in the hypobetalipoproteinaemic activity of SKF-525A in rats.
Topics: Animals; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholestyramine Resin; Diet; Drug Interactions; Hyperlipoproteinemias; Lipids; Lipoproteins; Lipoproteins, LDL; Male; Proadifen; Rats; Rats, Inbred Strains; Steroid Hydroxylases | 1982 |
[Diagnosis, clinical features and treatment of hyperlipidemias in children].
Topics: Adolescent; Arteriosclerosis; Child; Cholestyramine Resin; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Lipoproteins; Risk | 1982 |
[Hyperlipoproteinemias: experience of out-patient treatment of 112 patients (author's transl)].
Topics: Body Weight; Cholesterol; Cholestyramine Resin; Clofibrate; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Triglycerides | 1981 |
Dietary fiber and blood lipids: treatment of hypercholesterolemia with guar crispbread.
Topics: Adult; Aged; Bread; Cholesterol; Cholestyramine Resin; Female; Humans; Hyperlipoproteinemias; Lipids; Lipoproteins; Male; Middle Aged; Polysaccharides; Triglycerides | 1980 |
[Lipoproteins and hyperlipoproteinemias].
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipoproteinemias; Lipoproteins; Lipoproteins, LDL; Thyroxine; Triglycerides | 1980 |
[Therapy of hyperlipoproteinemias].
Topics: Cholestyramine Resin; Diet, Reducing; Exercise Therapy; Humans; Hyperlipoproteinemias; Ileum; Nicotinic Acids; Portacaval Shunt, Surgical | 1980 |
Multiple population models for multivariate random length data--with applications in clinical trials.
Topics: Biometry; Cholestyramine Resin; Controlled Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Humans; Hyperlipoproteinemias; Models, Statistical; Probability; Randomized Controlled Trials as Topic | 1995 |
Lack of left ventricular dysfunction associated with sustained exposure to hyperlipidemia following lung transplantation.
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Echocardiography; Female; Follow-Up Studies; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Immunosuppressive Agents; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Lung Transplantation; Male; Middle Aged; Myocardial Ischemia; Probucol; Radionuclide Angiography; Retrospective Studies; Triglycerides; Ventricular Dysfunction, Left; Ventricular Function, Left | 1997 |
The effects of cholestyramine on high density lipoprotein metabolism.
Topics: Apolipoproteins; Cholestyramine Resin; Female; Humans; Hyperlipoproteinemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Metabolism | 1979 |
Metabolism of plasma and biliary lipids in hyperlipoproteinaemia.
Topics: Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Lipid Metabolism; Lipids; Lipoproteins; Nicotinic Acids; Obesity; Triglycerides | 1979 |
Medical management of hyperlipidemia and the role of probucol.
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk | 1986 |
Rational drug therapy of the hyperlipoproteinemias, Part II.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol | 1986 |
[Effect of cholestyramine on the clinico-biochemical indices of ischemic heart disease patients].
Topics: Aged; Cholestyramine Resin; Coronary Disease; Drug Evaluation; Energy Metabolism; Humans; Hydroxyproline; Hyperlipoproteinemias; Lipids; Male; Middle Aged | 1987 |
[Drugs in hyperlipidemia].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypolipidemic Agents; Neomycin; Niacin | 1987 |
Interactions of the major risk factors for coronary heart disease.
Topics: Age Factors; Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Diet, Reducing; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Hypertension; Male; Physical Exertion; Risk; Smoking; Sodium Chloride | 1986 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis | 1985 |